Table II.
Stage | DE | RO | P-value |
---|---|---|---|
I | 4.1% (2 subjects) | 11.3% (11 subjects) | P>0.05 |
II | 28.6% (14 subjects) | 5.2% (5 subjects) | P<0.001 |
III | 67.4% (33 subjects) | 83.5% (81 subjects) | P=0.044 |
DE, German patient group; RO, Romanian patient group.
Stage | DE | RO | P-value |
---|---|---|---|
I | 4.1% (2 subjects) | 11.3% (11 subjects) | P>0.05 |
II | 28.6% (14 subjects) | 5.2% (5 subjects) | P<0.001 |
III | 67.4% (33 subjects) | 83.5% (81 subjects) | P=0.044 |
DE, German patient group; RO, Romanian patient group.